Massive Bet on Potential ‘Super Flu Drug’! Why Did Merck Spend $9.2 Billion to Acquire Cidara?
November 17, 2025 — 14:30 CST
This Data Is Locked!
This area is available only to Subscribers.
Merck has made a bold move in the pharmaceutical world by acquiring Cidara and its innovative flu drug CD388 for a whopping $9.2 billion. The... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
